Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Endocrinology, Diabetes & Metabolism|March 1, 2019
Adult-onset type 1 diabetes: Predictors of glycaemic controlDan Hesse, Louise Boysen, Martin Ridderstråle
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2013
Differential microRNA expression in blood in multiple sclerosisHelle Bach Søndergaard, Dan Hesse, Martin Krakauer, et al.
Pediatric Obesity|May 8, 2021
Liraglutide pharmacokinetics and exposure-response in adolescents with obesityKristin C Carlsson Petri, Paula M Hale, Dan Hesse, et al.
Journal of Comparative Effectiveness Research|December 19, 2022
Semaglutide treatment for obesity in teenagers: a plain language summary of the STEP TEENS research studyDaniel Weghuber, Klaus Boberg, Dan Hesse, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2010
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody productionChris J Hedegaard, Finn Sellebjerg, Martin Krakauer, et al.
Diabetes, Obesity & Metabolism|April 22, 2026
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 TrialsMinna Brændholt Olsen, Jon Griffin, Ulrike Hövelmann, et al.
Journal of Neuroinflammation|September 18, 2012
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosisJeppe Romme Christensen, Lars Börnsen, Dan Hesse, et al.
Plos One|June 16, 2012
Endogenous and recombinant type I interferons and disease activity in multiple sclerosisFinn Sellebjerg, Martin Krakauer, Signe Limborg, et al.
Obesity (Silver Spring, Md.)|May 17, 2023
Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mgAaron S Kelly, Silva Arslanian, Dan Hesse, et al.
Pageof 2